OncLive |
MSK’s CAR Trials Halted Temporarily Amid Safety Review
OncLive Six of these patients relapsed or were refractory to treatment, and two more died from complications that arose from allogeneic bone marrow transplantation, to which patients were transitioned after CAR therapy. The 2 patients whose deaths prompted the … |
|
Experimental drug could fight slow-growing cancers
OCRegister In one trial, 220 patients with recurrent chronic lymphocytic leukemia were given an intravenous drug called rituximab, a standard treatment. Half of participants were also given idelalisib twice a day in pill form. • Overall, 81 percent of patients … |
State College NewsPegula Ice Arena Makes Immediate ImpactState College NewsI learned that David Glen, who voluntarily missed three games after undergoing bone marrow transplant surgery earlier this year, is so much more than a hockey player. I was remi…
|
Biting amoeba acts a bit like the werewolf of parasites
Great Falls Tribune The amoebas colonize the large intestine and bore their way into the intestinal wall, in some cases bursting all the way through the intestine and invading organs such as the liver. Victims may suffer anything from diarrhea to â?? in rare cases â … |
|
Cars biggest threat to climate change?
Philippine Star Citing a “leaked” draft of the report, Bloomberg said the huge demand of consumer goods from countries like China, Brazil and India – which have to be delivered by trucks, trains, ship or planes – have contributed to the rising “new” pollution due to … |
Daily StarUltimate Warrior PREDICTED his OWN DEATH: Wrestling legend warned of …Daily StarUltimate Warrior PREDICTED his OWN DEATH: Wrestling legend warned of heart failure. WRESTLING legend The Ultimate Warrior died just 20 hours after predicting hi…
Science World Report |
WHO Calls For ‘Concerted Effort’ To Bring Down Hepatitis C Drug Costs
Huffington Post By Ben Hirschler LONDON, April 9 (Reuters) – The World Health Organisation wants a “concerted effort” to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus but are unaffordable for most infected people … Gilead aims to license hepatitis C drug to 3-4 Indian firmsReuters WHO joins clamor to make new hepatitis C pills affordableYahoo News |
|
Pipeline Progress at Prothena
Zacks.com Moreover, Roche and Prothena will initiate a research collaboration focusing on optimizing early stage antibodies targeting alpha-synuclein. This research collaboration will include incorporation of Roche’s proprietary Brain Shuttle(TM) technology to … Why Prothena Corporation PLC Shares Leaped HigherMotley Fool First Human Dosed in Phase 1 Study of PRX002 for Treatment of Parkinson’s …GlobeNewswire (press release) |
Steroid dose increase after CRS unnecessary to prevent hypotensionClinical AdvisorPatients having major colorectal surgery while receiving steroid treatment are routinely given high-dose corticosteroids to prevent acute perioperative adrenal insufficie…
Voice of America |
WHO Issues Guidelines for Hepatitis C Treatment
Voice of America GENEVA — The World Health Organization is issuing its first-ever global guidelines on treating hepatitis C, a liver disease that kills between 350,000 and 500,000 people every year. WHO said the guidelines will reduce deaths from hepatitis C by … WHO Guidelines May Help With Price Reductions For Hepatitis C DrugsIntellectual Property Watch |